Balyasny Asset Management LLC Abcam PLC Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$21.54 - $24.41 $68.8 Million - $78 Million	3,194,254 Added 815.54%	3,585,928 $81.1 Million
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $3.02 Million - $5.85 Million	238,995 Added 156.53%	391,674 $9.58 Million
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $1.76 Million - $2.32 Million	135,423 Added 784.79%	152,679 $2.06 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $88,475 - $108,052	6,356 Added 58.31%	17,256 $268,000
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $145,624 - $182,575	10,900 New	10,900 $163,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.